Patents
The laboratory holds some patents relating to the research and development of antivirals and nanotechnologies:
(2009) Novel antiviral peptides, patent number: MI2009A001425.
(2012) Novel antipathogenic peptides, patent number: US 2012/0121623 A1.
(2011) Novel antipathogenic peptides, patent number: WO/2011/015628.
(2012) 䐾合保温防火板, patent number: CN 201110316296.4.
(2011) Membrane for nanocapsule, nanocapsule comprising the same and its use, patent number: TO2011A000884.
(2016) Oxisterols for use in the treatment and prevention of diseases caused by viruses, patent number: WO2016001870 A1.
(2021) Oxisterol for use in the treatment and prevention of pathologies caused by coronaviruses, patent number: PCT IB2021053421.